Our vision is to improve human well-being by empowering researchers to better understand complex diseases and develop personalized therapies. We develop and market PET nuclear imaging products to allow medical professionals at leading hospitals, universities and pharmaceutical companies to non-invasively visualize and measure biochemical processes at the molecular level.
Applications for our products include preclinical drug development and disease research in oncology, neurological, and cardiovascular areas. Our multimodal preclinical in vivo imaging systems feature ultra-compact scanner footprints and excellent resolution, sensitivity and image quality.
Company Details
- Employees
- 17
- Founded
- 2011
- Address
- 800-136 Market Ave, Winnipeg,manitoba R3b 0p4,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cubresa.com
- Keywords
- Molecular Imaging, Preclinical Imaging, Drug Discovery, Disease and Therapeutic Research, Life Science Research, Nuclear Medicine, PET/MRI, Simultaneous PET/MRI Imaging.
- HQ
- Winnipeg, Manitoba
Cubresa Inc. Questions
Cubresa Inc.'s website is cubresa.com
Cubresa Inc.'s LinkedIn profile is https://ca.linkedin.com/company/cubresa
Cubresa Inc. has
17 employees.
View email and phone details for 17
employees at Cubresa Inc..
Cubresa Inc.'s industry is
Biotechnology Research
Cubresa Inc.'s top competitors are
Alaya Biosciences Inc.,
Subtle Medical,
Healda Inc,
Twc Nutrition,
Prenuvo,
Surgical Reality,
Smartrend Manufacturing Group (Smg),
Canam Bioresearch Inc.,
Coreline Soft,
Cercare Medical.
Cubresa Inc.'s categories are Biotechnology Research
Cubresa Inc.'s founding year is 2011
